INTERNATIONAL STRATEGIC HEALTHCARE COMMUNICATIONS

Experienced, trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, digital health, biotech and healthcare services, large & small.

WHAT WE DO

COMMUNICATING A COMPELLING GROWTH STORY TO THE INVESTMENT COMMUNITY

Effectively communicating a company’s strategy, growth ambitions, and the reasons to “invest now” is critical for management teams as they seek to build investor confidence and support. We have an exceptional track record in advising globally on healthcare fund raisings, IPOs and M&A transactions.

FIND OUT MORE

Insights & Latest News

Great news for the #biobasedeconomy: #AMSilk GmbH has closed a Series C financing at €29m to accelerate and expand commercialisation of its microbially produced silk fibres. @NovoVentures @Cargill @MIGFonds

https://european-biotechnology.com/up-to-date/latest-news/news/recombinant-silk-producer-amsilk-raises-eur29m.html

Time is flying! #BioEquity is next week! Europe’s premier international showcase for financial dealmakers & #biopharma executives to meet rising #biotechs! Set to be the largest event ever hosted by @BioCentury & @EBDgroup! Register now: https://conferences.biocentury.com/bioequity-europe #healthcare #BEE21

Optimum's 13th Annual

Healthcare Investor Conference

October 2021 | LONDON VIRTUAL

More info

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH